DaVita Inc. (DVA)

Market Cap	8.28B
Revenue (ttm)	13.32B
Net Income (ttm)	771.92M
Shares Out	70.60M
EPS (ttm)	9.76
PE Ratio	12.01
Forward PE	9.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	939,088
Open	121.55
Previous Close	121.55
Day's Range	116.72 - 121.80
52-Week Range	115.39 - 179.60
Beta	0.99
Analysts	Hold
Price Target	145.00 (+23.65%)
Earnings Date	Oct 29, 2025

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 31, 1995
• Employees: 76,000
• Stock Exchange: NYSE
• Ticker Symbol: DVA
• Website: https://www.davita.com

Financial Performance

In 2024, DaVita's revenue was $12.82 billion, an increase of 5.56% compared to the previous year's $12.14 billion. Earnings were $936.34 million, an increase of 35.40%.

Analyst Summary

According to 4 analysts, the average rating for DVA stock is "Hold." The 12-month stock price target is $145.0, which is an increase of 23.65% from the latest price.

Price Target

$145.0

(23.65% upside)

Analyst Consensus: Hold